Should patients with light chain myeloma be more wary of disease outcomes?

Should patients with light chain myeloma be more wary of disease outcomes?

In this week’s video, Dr. Brian G.M. Durie explains that the underlying biology of light chain myeloma is very similar to IgG or IgA myeloma.

BOTTOM LINE:

If you have light chain myeloma, you are not at a higher risk for poorer outcomes than those patients with other types of myeloma.

Please subscribe to our channel!
Subscribe to International Myeloma Foundation: http://bit.ly/XlUtPE

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: http://facebook.com/myeloma
Google+: http://gplus.to/imfmyeloma
IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyeloma)
Dr. Durie on twitter: @BrianDurieMD (http://twitter.com/brianduriemd)

Support the IMF! http://bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard YouTube License